StockWatch
·
Medical/Dental Instruments
Quarterly ResultMay 13, 2026, 08:37 AM

SS Innovations Q1 Revenue $11.1M, up 116.8%; Net Loss Narrows to $3.6M

AI Summary

SS Innovations International, Inc. reported record first quarter 2026 revenue of $11.1 million, marking a 116.8% increase year-over-year, driven by robust growth in SSi Mantra installations and procedures. The company's net loss narrowed to $3.6 million, and gross margin significantly expanded to 48.0%. Additionally, SS Innovations successfully completed a private placement raising $18.6 million and secured regulatory approvals for its SSi Mantra system in new international markets, with plans to enter the US and EU markets in 2026.

Key Highlights

  • Q1 2026 revenue increased 116.8% to $11.1 million from $5.1 million in Q1 2025.
  • Net loss narrowed to $3.6 million, or $(0.02) per diluted share, from $5.7 million.
  • Gross margin expanded to 48.0% from 21.2% in the prior year quarter.
  • SSi Mantra installations totaled 26, a 73.3% increase from 15 in Q1 2025.
  • Cumulative SSi Mantra installed base reached 194 across eleven countries.
  • Completed a private placement, raising approximately $18.6 million in gross proceeds.
  • Received regulatory approvals for SSi Mantra in Sri Lanka, Kenya, Indonesia, and the Philippines.
  • Aims for US FDA 510(k) review completion and EU CE marking certification in 2026.